Patent Assignment
Reel/Frame 025713/0821
Change of Name
Recorded: 2011-01-28
Pages: 8
Assignor
RX3 PHARMACEUTICALS, INC.
Executed: 2007-02-22
Assignee
TRIUS THERAPEUTICS, INC.
6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Method for Identifying Drug-Sensitizing Antisense Dna Fragments and Use Thereof
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 29, 2007
From: HASELBECK, ROBERT; HILGERS, MARK; SHAW, KAREN; BROWN-DRIVER, VICKIE
To: RX3 PHARMACEUTICALS
Reel/Frame 019110/0947 →
Security Agreement
Nov 10, 2009
From: TRIUS THERAPEUTICS, INC.
To: SOFINNOVA VENTURE PARTNERS VII, L.P., AS COLLATERAL AGENT
Reel/Frame 023496/0079 →
Release of Security Interest
Aug 26, 2010
From: SOFINNOVA VENTURE PARTNERS VII, L.P.
To: TRIUS THERAPEUTICS, INC.
Reel/Frame 024895/0248 →
Security Agreement
Nov 13, 2013
From: OPTIMER PHARMACEUTICALS, INC.; TRIUS THERAPEUTICS INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 031628/0850 →
Release of Security Interest
Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
Change of Name
Sep 2, 2015
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 036528/0029 →
Nunc Pro Tunc Assignment
Sep 3, 2015
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036484/0796 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →